• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过高通量对接鉴定出的蛋白酪氨酸磷酸酶Shp2的特异性抑制剂。

Specific inhibitors of the protein tyrosine phosphatase Shp2 identified by high-throughput docking.

作者信息

Hellmuth Klaus, Grosskopf Stefanie, Lum Ching Tung, Würtele Martin, Röder Nadine, von Kries Jens Peter, Rosario Marta, Rademann Jörg, Birchmeier Walter

机构信息

Max Delbrück Center for Molecular Medicine, Robert Rössle Strasse 10, D-13125 Berlin, Germany.

出版信息

Proc Natl Acad Sci U S A. 2008 May 20;105(20):7275-80. doi: 10.1073/pnas.0710468105. Epub 2008 May 14.

DOI:10.1073/pnas.0710468105
PMID:18480264
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2438240/
Abstract

The protein tyrosine phosphatase Shp2 is a positive regulator of growth factor signaling. Gain-of-function mutations in several types of leukemia define Shp2 as a bona fide oncogene. We performed a high-throughput in silico screen for small-molecular-weight compounds that bind the catalytic site of Shp2. We have identified the phenylhydrazonopyrazolone sulfonate PHPS1 as a potent and cell-permeable inhibitor, which is specific for Shp2 over the closely related tyrosine phosphatases Shp1 and PTP1B. PHPS1 inhibits Shp2-dependent cellular events such as hepatocyte growth factor/scatter factor (HGF/SF)-induced epithelial cell scattering and branching morphogenesis. PHPS1 also blocks Shp2-dependent downstream signaling, namely HGF/SF-induced sustained phosphorylation of the Erk1/2 MAP kinases and dephosphorylation of paxillin. Furthermore, PHPS1 efficiently inhibits activation of Erk1/2 by the leukemia-associated Shp2 mutant, Shp2-E76K, and blocks the anchorage-independent growth of a variety of human tumor cell lines. The PHPS compound class is therefore suitable for further development of therapeutics for the treatment of Shp2-dependent diseases.

摘要

蛋白酪氨酸磷酸酶Shp2是生长因子信号传导的正向调节因子。多种白血病中的功能获得性突变将Shp2定义为一种真正的癌基因。我们对结合Shp2催化位点的小分子化合物进行了高通量计算机筛选。我们已鉴定出苯腙基吡唑啉酮磺酸盐PHPS1是一种强效且可透过细胞的抑制剂,它对Shp2具有特异性,而对密切相关的酪氨酸磷酸酶Shp1和PTP1B则不然。PHPS1抑制依赖Shp2的细胞事件,如肝细胞生长因子/分散因子(HGF/SF)诱导的上皮细胞分散和分支形态发生。PHPS1还阻断依赖Shp2的下游信号传导,即HGF/SF诱导的Erk1/2丝裂原活化蛋白激酶的持续磷酸化和桩蛋白的去磷酸化。此外,PHPS1有效抑制白血病相关的Shp2突变体Shp2-E76K对Erk1/2的激活,并阻断多种人类肿瘤细胞系的非锚定依赖性生长。因此,PHPS化合物类适合进一步开发用于治疗依赖Shp2疾病的疗法。

相似文献

1
Specific inhibitors of the protein tyrosine phosphatase Shp2 identified by high-throughput docking.通过高通量对接鉴定出的蛋白酪氨酸磷酸酶Shp2的特异性抑制剂。
Proc Natl Acad Sci U S A. 2008 May 20;105(20):7275-80. doi: 10.1073/pnas.0710468105. Epub 2008 May 14.
2
SHP2 inhibitor PHPS1 ameliorates acute kidney injury by Erk1/2-STAT3 signaling in a combined murine hemorrhage followed by septic challenge model.SHP2 抑制剂 PHPS1 通过 Erk1/2-STAT3 信号通路改善了出血后继发脓毒症的小鼠急性肾损伤。
Mol Med. 2020 Sep 21;26(1):89. doi: 10.1186/s10020-020-00210-1.
3
PTPN11 (SHP2) Is Indispensable for Growth Factors and Cytokine Signal Transduction During Bovine Oocyte Maturation and Blastocyst Development.PTPN11(SHP2)在牛卵母细胞成熟和囊胚发育过程中对于生长因子和细胞因子信号转导是必不可少的。
Cells. 2019 Oct 18;8(10):1272. doi: 10.3390/cells8101272.
4
New approaches to prevent LEOPARD syndrome-associated cardiac hypertrophy by specifically targeting Shp2-dependent signaling.通过特异性靶向 Shp2 依赖性信号通路预防 LEOPARD 综合征相关心肌肥厚的新方法。
J Biol Chem. 2013 Jun 21;288(25):18335-44. doi: 10.1074/jbc.M113.483800. Epub 2013 May 14.
5
Interaction of scaffolding adaptor protein Gab1 with tyrosine phosphatase SHP2 negatively regulates IGF-I-dependent myogenic differentiation via the ERK1/2 signaling pathway.支架衔接蛋白Gab1与酪氨酸磷酸酶SHP2的相互作用通过ERK1/2信号通路负向调节IGF-I依赖的成肌分化。
J Biol Chem. 2008 Aug 29;283(35):24234-44. doi: 10.1074/jbc.M803907200. Epub 2008 Jun 23.
6
Selective inhibitors of the protein tyrosine phosphatase SHP2 block cellular motility and growth of cancer cells in vitro and in vivo.蛋白酪氨酸磷酸酶SHP2的选择性抑制剂可在体外和体内阻断癌细胞的细胞运动性和生长。
ChemMedChem. 2015 May;10(5):815-26. doi: 10.1002/cmdc.201500015. Epub 2015 Apr 15.
7
Discovery of a Novel Inhibitor of the Protein Tyrosine Phosphatase Shp2.新型蛋白酪氨酸磷酸酶Shp2抑制剂的发现
Sci Rep. 2015 Dec 2;5:17626. doi: 10.1038/srep17626.
8
Hepatocyte growth factor (HGF) signals through SHP2 to regulate primary mouse myoblast proliferation.肝细胞生长因子(HGF)通过SHP2发出信号,以调节原代小鼠成肌细胞的增殖。
Exp Cell Res. 2009 Aug 1;315(13):2284-92. doi: 10.1016/j.yexcr.2009.04.011. Epub 2009 Apr 23.
9
Tyrosine phosphatase Shp2 mediates the estrogen biological action in breast cancer via interaction with the estrogen extranuclear receptor.酪氨酸磷酸酶Shp2通过与雌激素核外受体相互作用介导乳腺癌中的雌激素生物学作用。
PLoS One. 2014 Jul 21;9(7):e102847. doi: 10.1371/journal.pone.0102847. eCollection 2014.
10
Therapeutic potential of targeting the oncogenic SHP2 phosphatase.靶向致癌性SHP2磷酸酶的治疗潜力。
J Med Chem. 2014 Aug 14;57(15):6594-609. doi: 10.1021/jm5006176. Epub 2014 Jul 28.

引用本文的文献

1
Investigating the role of UBASH3B in cancer: structural relevance, physiological functions, and therapeutic possibilities.探究UBASH3B在癌症中的作用:结构相关性、生理功能及治疗潜力
J Exp Clin Cancer Res. 2025 Aug 30;44(1):262. doi: 10.1186/s13046-025-03511-7.
2
Blocking the PD-1 signal transduction by occupying the phosphorylated ITSM recognition site of SHP-2.通过占据SHP-2的磷酸化ITSM识别位点来阻断PD-1信号转导。
Sci China Life Sci. 2025 Jan;68(1):189-203. doi: 10.1007/s11427-024-2706-2. Epub 2024 Aug 29.
3
Discovery of TK-642 as a highly potent, selective, orally bioavailable pyrazolopyrazine-based allosteric SHP2 inhibitor.发现TK-642是一种高效、选择性、口服生物可利用的基于吡唑并吡嗪的变构SHP2抑制剂。
Acta Pharm Sin B. 2024 Aug;14(8):3624-3642. doi: 10.1016/j.apsb.2024.03.028. Epub 2024 Mar 26.
4
Ionizable networks mediate pH-dependent allostery in SH2 signaling proteins.可电离网络介导SH2信号蛋白中pH依赖性变构调节。
bioRxiv. 2024 Aug 21:2024.08.21.608875. doi: 10.1101/2024.08.21.608875.
5
Therapeutic potential of targeting protein tyrosine phosphatases in liver diseases.靶向蛋白酪氨酸磷酸酶在肝脏疾病中的治疗潜力
Acta Pharm Sin B. 2024 Aug;14(8):3295-3311. doi: 10.1016/j.apsb.2024.05.006. Epub 2024 May 13.
6
Synthesis of novel 4-substituted isatin Schiff base derivatives as potential autophagy inducers and evaluation of their antitumour activity.新型4-取代异吲哚酮席夫碱衍生物的合成及其作为潜在自噬诱导剂的研究与抗肿瘤活性评价
Mol Divers. 2025 Jun;29(3):1983-2000. doi: 10.1007/s11030-024-10954-1. Epub 2024 Aug 7.
7
Rebamipide and Derivatives are Potent, Selective Inhibitors of Histidine Phosphatase Activity of the Suppressor of T Cell Receptor Signaling Proteins.雷贝拉唑和衍生物是 T 细胞受体信号转导抑制蛋白的组氨酸磷酸酶活性的有效和选择性抑制剂。
J Med Chem. 2024 Feb 8;67(3):1949-1960. doi: 10.1021/acs.jmedchem.3c01763. Epub 2024 Jan 22.
8
Identification and Optimization of Protein Tyrosine Phosphatase Inhibitors Via Fragment Ligation.通过片段连接鉴定和优化蛋白酪氨酸磷酸酶抑制剂。
Methods Mol Biol. 2024;2743:239-270. doi: 10.1007/978-1-0716-3569-8_16.
9
Targeting Src homology phosphatase 2 ameliorates mouse diabetic nephropathy by attenuating ERK/NF-κB pathway-mediated renal inflammation.靶向Src 同源磷酸酶 2 通过抑制 ERK/NF-κB 通路介导的肾脏炎症改善小鼠糖尿病肾病。
Cell Commun Signal. 2023 Dec 18;21(1):362. doi: 10.1186/s12964-023-01394-9.
10
Overcoming Immune Checkpoint Therapy Resistance with SHP2 Inhibition in Cancer and Immune Cells: A Review of the Literature and Novel Combinatorial Approaches.通过抑制SHP2克服癌症和免疫细胞中的免疫检查点治疗耐药性:文献综述与新型联合方法
Cancers (Basel). 2023 Nov 13;15(22):5384. doi: 10.3390/cancers15225384.

本文引用的文献

1
The MET receptor tyrosine kinase in invasion and metastasis.MET受体酪氨酸激酶在侵袭和转移中的作用
J Cell Physiol. 2007 Nov;213(2):316-25. doi: 10.1002/jcp.21183.
2
PTP1B as a drug target: recent developments in PTP1B inhibitor discovery.蛋白酪氨酸磷酸酶1B作为药物靶点:蛋白酪氨酸磷酸酶1B抑制剂发现的最新进展
Drug Discov Today. 2007 May;12(9-10):373-81. doi: 10.1016/j.drudis.2007.03.011. Epub 2007 Apr 6.
3
C-acylations of polymeric phosphoranylidene acetates for C-terminal variation of peptide carboxylic acids.用于肽羧酸C端变异的聚合亚膦酰基乙酸酯的C-酰化反应。
Org Lett. 2007 Mar 15;9(6):949-52. doi: 10.1021/ol062754+. Epub 2007 Feb 17.
4
The role of Shp2 (PTPN11) in cancer.Shp2(PTPN11)在癌症中的作用。
Curr Opin Genet Dev. 2007 Feb;17(1):23-30. doi: 10.1016/j.gde.2006.12.011. Epub 2007 Jan 16.
5
Discovery of protein phosphatase inhibitor classes by biology-oriented synthesis.通过生物导向合成发现蛋白质磷酸酶抑制剂类别。
Proc Natl Acad Sci U S A. 2006 Jul 11;103(28):10606-11. doi: 10.1073/pnas.0601490103. Epub 2006 Jun 29.
6
A role for the scaffolding adapter GAB2 in breast cancer.支架衔接蛋白GAB2在乳腺癌中的作用。
Nat Med. 2006 Jan;12(1):114-21. doi: 10.1038/nm1341. Epub 2005 Dec 20.
7
Enhanced sensitivity to inhibition of SHP2, STAT5, and Gab2 expression in chronic myeloid leukemia (CML).慢性髓性白血病(CML)中对SHP2、STAT5和Gab2表达抑制的敏感性增强。
Blood. 2006 Apr 15;107(8):3279-87. doi: 10.1182/blood-2005-08-3087. Epub 2005 Nov 8.
8
Overexpression of Shp2 tyrosine phosphatase is implicated in leukemogenesis in adult human leukemia.Shp2 酪氨酸磷酸酶的过表达与成人白血病的白血病发生有关。
Blood. 2005 Nov 1;106(9):3142-9. doi: 10.1182/blood-2004-10-4057. Epub 2005 Jul 19.
9
Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations.由Shp2(PTPN11)突变引发的白血病小鼠模型的预后、治疗及机制研究意义
Cancer Cell. 2005 Feb;7(2):179-91. doi: 10.1016/j.ccr.2005.01.010.
10
Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia.人类实体瘤和成人急性髓性白血病中与努南综合征相关的SHP2/PTPN11基因的激活突变。
Cancer Res. 2004 Dec 15;64(24):8816-20. doi: 10.1158/0008-5472.CAN-04-1923.